3rd CMC-China 2021
Nthawi: Seputembara 29-30, 2021
Malo owonetsera: CD Hall, Suzhou International Expo Center, Suzhou City, Province la JIangsu, China.
Synergy of Centralised China's Drug Volume-based Purchasing and Medical Insurance Negotiation Policy imakulitsa ululu wakuphatikizana kwamakampani opanga mankhwala ndikuwongolera mtundu wamankhwala odziwika bwino. mankhwala adachotsedwa ku inshuwaransi yazachipatala, kumasula malo ochulukirapo a mankhwala omwe ali ndi mtengo weniweni wachipatala: NMPA kujowina ICH ndi kukhazikitsidwa kwa dongosolo la MAH kunawonjezera liwiro la kutukuka kwa mafakitale a ntchito zopangira mankhwala.
Kwa nthawi yayitali, makampani opanga mankhwala amayang'ana kwambiri "zatsopano" ndikunyalanyaza kufunikira kwa mankhwala mogwirizana ndi momwe dziko likuyendera komanso unyolo wonse wamakampani opanga mankhwala, monga kuphatikizika kwa API intermediates ndi chain chain; Kapena njira yotsatsira innovative drugs.Innovation for innovation's sake ndi nsanja mumlengalenga.
Kodi makampani opanga mankhwala okhala ndi mikhalidwe yaku China ayenera kupita bwanji m'tsogolo? Ili siliri vuto pazamankhwala a R&D, komanso kuti gulu lonse lazamankhwala liyenera kuganizira.
Pa Seputembara 29 mpaka 30, 2021, msonkhano wachitatu wa China Chemical and Biological Pharmaceutical Industry Conference udzachitika ku Suzhou International Expo Center. Mutu wa msonkhanowu ndi "Kulumikiza gulu lonse lamakampani opanga mankhwala kuti athetse kufunikira kwamankhwala komwe sikunakwaniritsidwe mogwirizana ndi momwe dziko la China lilili. ", Pamsonkhanowu, pafupifupi 6000 ~ 8000 otenga nawo mbali adzakambirana za API intermediates, pathway inhibitor, ndi kusintha ndi luso, kenako gwero la mankhwala atsopano m'mbali zonse kuti afufuze zamakono, ndondomeko ndi zothetsera.
Pamene kusintha kwa msika ndi ndondomeko zikuyendetsedwa, makampani opanga mankhwala achikhalidwe akutukuka ndikusintha, makampani atsopano a Biotech akuchulukirachulukira, ndipo makampani a CXO okhudzana ndi preclinical, chipatala ndi CMC nawonso akukula. , mankhwala osokoneza bongo ndi mankhwala achilengedwe.Transnational Cooperation License in/out, maiko akunja ophatikizana ndi kugula nawonso ali ofala.
Potengera izi, ife ndi mazana a mabizinesi azamankhwala timagwira limodzi Msonkhano wachitatu wa China International Biological & Chemical Pharmaceutical Industry (The 3rd CMC-China 2021) ku Suzhou, mzinda waukulu kwambiri wamakampani opanga mankhwala.Mabwalo asanu ndi limodzi amitu amakhazikitsidwa pamsonkhanowu, wokhudza gawo lonse la ma macro-molecule & mamolekyu ang'onoang'ono, mankhwala opangidwa ndi generic ndi zatsopano, unyolo wapamwamba & pansi wa zosakaniza zogwira ntchito zamankhwala (API) ndi kukonzekera kwamankhwala.
Pamsonkhano wachitatu wa CMC-China, mupeza kutanthauzira kwa mfundo zamafakitale ndi kugawana ukadaulo wapamwamba, kuphimba mankhwala a antibody, katemera ndi ukadaulo wa mRNA, mankhwala opangira mankhwala ndi kuvomerezedwa kwa projekiti, kafukufuku ndi chitukuko, zamankhwala ndi kupanga, mankhwala obiriwira enieni. teknoloji yolimbana, ndi zina zotero. Pamsonkhanowu, mungapeze mwayi wambiri wamalonda m'dera la mankhwala opangira mankhwala (API), mankhwala apakatikati ndi othandizira mankhwala, zida zonyamula, zida, zida, zogwiritsira ntchito, komanso mankhwala & chipatala CRO, CMO. ndi ntchito zokhudzana ndi MAH.Pamsonkhanowu, mudzakumana ndi gulu la abwenzi ndi ogwira nawo ntchito!
Nthawi yotumiza: Sep-28-2021